Filtered By:
Management: Budgets

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 83 results found since Jan 2013.

Mechanical Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion in Argentina: An Economic Analysis
This study was designed to estimate the economic value and the budget impact of incorporating MT after thrombolysis, simulating scenarios from Argentinian compulsory social health insurance (Obras Sociales) and private insurances (Empresas de Medicina Prepaga).
Source: Journal of Stroke and Cerebrovascular Diseases - June 15, 2022 Category: Neurology Authors: Pedro Lylyk, Juan Cirio, Carlos Toranzo, Eleonora Aiello, Juan Valencia, Daniela Paredes-Fern ández Source Type: research

TCT 2017: Boston Scientific touts lowered hemorrhagic stroke rate, cost for patients in Watchman studies
Boston Scientific (NYSE:BSX) today released combined 5-year outcomes data from both the Prevail and Protect-AF study of its Watchman left atrial appendage closure device, touting it as a safe and effective an alternative to long-term warfarin therapy for patients with non-valvular atrial fibrillation. Five-year data from the Prevail study was published online today in the Journal of the American College of Cardiology. In both trials, the Marlborough, Mass.-based company compared the Watchman device to warfarin treatment for stroke prevention in patients with non-valvular AF with follow-ups out to five years. A combined an...
Source: Mass Device - November 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Source Type: news

HTA42 The Budget Impact Analysis of Acute Stroke Centre Expansion in Ministry of Health Malaysia
This study aimed to assess the budget impact analysis of expanding acute stroke services/centres in the public healthcare setting in Malaysia. The number of hospitalized stroke cases in the next five years is projected from the latest national stroke registry.
Source: Value in Health - June 26, 2022 Category: International Medicine & Public Health Authors: S Thanimalai, YV Yong, I Looi, WC Law, Aziz Z Abdul Source Type: research

Medicare beneficiary out-of-pocket spending for stroke prevention in non-valvular Atrial Fibrillation: a budget analysis
Healthcare costs today are increasingly being shifted from payers to patients, yet few providers factor patient costs into treatment decisions. Recent advancements in stroke prevention in atrial fibrillation (AF) have resulted in new treatment options where previously there were few. While the clinical benefit and cost effectiveness of these treatments are supported by a growing body of evidence, the cost impact to patients has not been explored. This analysis sought to quantify patient out-of-pocket costs for three stroke prevention strategies: warfarin, dabigatran and left atrial appendage closure (LAAC) with the Watchman Device.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: S. Armstrong, S.L. Amorosi, G. Erickson, P. Patel, K. Stein Source Type: research

The Impact of Outpatient Rehabilitation Medicare Reimbursement Caps on Utilization and Cost of Rehabilitation Care after Ischemic Stroke: Do Caps contain costs?
To estimate the proportion of ischemic stroke patients who fall within and above the total outpatient rehabilitation caps before and after the Balanced Budget Act of 1997 (BBA 1997) took effect. In addition, estimate the cost of post-stroke outpatient rehabilitation cost and resource utilization in these patients prior to and after the implementation of the caps.
Source: Archives of Physical Medicine and Rehabilitation - July 28, 2015 Category: Rehabilitation Authors: Annie N. Simpson, Heather S. Bonilha, Abby S. Kazley, James S. Zoller, Kit N. Simpson, Charles Ellis Source Type: research

Call for Tender: Innovative Post-Stroke Tool
The European pre-commercial procurement MAGIC project has launched its call for tender to find suppliers who can develop and test solutions to improve stroke recovery, home-based rehabilitation and to empower stroke patients following hospital discharge. The budget for this call is about €3,6 million.
Source: eHealth News EU - November 2, 2016 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals
by Nicole Lowres, Jake Olivier, Tze-Fan Chao, Shih-Ann Chen, Yi Chen, Axel Diederichsen, David A. Fitzmaurice, Juan Jose Gomez-Doblas, Joseph Harbison, Jeff S. Healey, F. D. Richard Hobbs, Femke Kaasenbrood, William Keen, Vivian W. Lee, Jes S. Lindholt, Gregory Y. H. Lip, Georges H. Mairesse, Jonathan Mant, Julie W. Martin, Enrique Mart ín-Rioboó, David D. McManus, Javier Muñiz, Thomas Münzel, Juliet Nakamya, Lis Neubeck, Jessica J. Orchard, Luis Ángel Pérula de Torres, Marco Proietti, F. Russell Quinn, Andrea K. Roalfe, Roopinder K. Sandhu, Renate B. Schnabel, Breda Smyth, Apurv Soni, Robert Tieleman, Jiguang Wang, ...
Source: PLoS Medicine - September 24, 2019 Category: Internal Medicine Authors: Nicole Lowres Source Type: research

PND36 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Programa De Atencion medica Integral Pami in Argentina
Stroke is responsible for mortality and long-term disability in Argentina. Available treatments for stroke due to Large Vessel Occlusion (LVO) are Thrombolysis (IV-tPA) and Mechanical Thrombectomy (MT). However, despite its clinical benefits, MT coverage in Argentina and PAMI is low. A Budget-Impact Analysis (BIA) was conducted to estimate the financial impact of incorporating MT after IV-TPA in PAMI for the elderly.
Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: P. Lylyk, J. Cirio, C. Toranzo, E.C. Aiello, D. Paredes, J. Valencia Source Type: research

PND28 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Obras Sociales and Empresas De Medicina Prepaga in Argentina
Stroke is associated with high clinical and economic burden of disease. Available treatments for stroke due to Large Vessel Occlusion (LVO) in Argentina are Thrombolysis (IV-tPA) and Mechanical Thrombectomy (MT). Despite its clinical benefits, MT coverage in Argentina is low. A Budget-Impact Analysis (BIA) was conducted to estimate the financial impact of incorporating MT after IV-TPA in Obras Sociales and Empresas de Medicina Prepaga (EMP) in Argentina.
Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: P. Lylyk, J. Cirio, C. Toranzo, E.C. Aiello, D. Paredes, J. Valencia Source Type: research

The Move Towards Full Implementation Of The Nice Guidelines For Stroke Prevention In Atrial Fibrillation: The Potential Cost And Clinical Impact
Updated treatment guidelines for atrial fibrillation (AF) have been released by the National Institute for Health and Care Excellence (NICE) in the United Kingdom and highlight a current shortfall in the prescribing of anticoagulants to patients with AF despite the importance of stroke prevention. A model was designed for use as a planning tool for Clinical Commissioning Groups (CCGs) looking to budget for the future move towards full implementation of the NICE guidelines.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: G.E. Shields, A.M. Chapman Source Type: research

Estimation of Costs Associated With Stroke In Diabetic Patients in Madrid (Spain) Using A New Simulation Model
Diabetes (DM) has a relevant impact on health care budgets mainly due to its high prevalence and its chronic and acute complications. Isquemic stroke (IS) is one of the macrovascular complications associated with DM and its incidence increases with the presence of some risk factors such as hypertension and obesity.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: C. Sánchez-Piedra, S. García-Pérez, A. Sarría-Santamera Source Type: research

Budget Impact Analysis of Botulinium Toxin Type A In Treatment of Post-Stroke Spasticity In The Russian Federation
To conduct budget impact analysis of abobotulinumtoxinA, onabotulinumtoxinA, incobotulinumtoxinA in patients with post-stroke spasticity in Russia for 1-year period. Physical therapy was used in all therapy schemes.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: R. Yagudina, A. Kulikov, D. Ugrekhelidze Source Type: research

Bridging the Gap in Neurotherapeutic Discovery and Development: The Role of the National Institute of Neurological Disorders and Stroke in Translational Neuroscience
This article provides an overview of NINDS-funded therapy development programs offered by the NINDS Office of Translational Research.
Source: Neurotherapeutics - June 17, 2015 Category: Neurology Source Type: research

Impact of Outpatient Rehabilitation Medicare Reimbursement Caps on Utilization and Cost of Rehabilitation Care After Ischemic Stroke: Do Caps Contain Costs?
To estimate the proportion of patients with ischemic stroke who fall within and above the total outpatient rehabilitation caps before and after the Balanced Budget Act of 1997 took effect; and to estimate the cost of poststroke outpatient rehabilitation cost and resource utilization in these patients before and after the implementation of the caps.
Source: Archives of Physical Medicine and Rehabilitation - July 28, 2015 Category: Rehabilitation Authors: Annie N. Simpson, Heather S. Bonilha, Abby S. Kazley, James S. Zoller, Kit N. Simpson, Charles Ellis Tags: Original research Source Type: research

Real-World Data And Budget Impact Analysis for Incobotulinum Toxin A and Onabotulinum Toxin A for Upper Limb Post-Stroke Spasticity At A Uk Centre
Botulinum toxins (BT) are a valuable treatment option for patients with post-stroke upper-limb spasticity (PS-ULS), which affects 33,000 patients in the UK. Xeomin (incobotulinum toxin A) and Botox (onabotulinum toxin A) are two BTs licensed for the treatment of PS-ULS. The treatment costs for Xeomin and Botox will depend on their real-world usage.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Robertson, P Datta, J Kusel, S Page, J Soon Source Type: research